Gateway to the largest biotechnology sector in Australia

Find

Victorian Platform Technologies

Find Infrastructure

What's this

Victorian Biotech Companies & Providers

Advanced Search
What's this

EMBL - Australia

Welcome to EMBL Australia.


EMBL Australia was launched on 29th March 2010, making Australia the first Associate Member of the European Molecular Biology Laboratory (EMBL). EMBL Australia provides Australian researchers access to EMBL through activities such as funded research positions, collaborative ventures and the formation of research institutes.

Australian Research will be internationalised through the relationship with EMBL

EMBL Australia will foster Australian research excellence through integrated research networks that connect to global partnerships. It will drive enhanced research quality through the development of world class scientific leaders. The centrepiece of EMBL Australia will be the Partner Laboratory Network of young research groups that will create new paradigm for education, training and highly collaborative research across Australia.

The objective is to enhance Australia’s international competitiveness in the life sciences and strengthen Australia’s emerging position as a leader in biotechnology research.  EMBL Australia aims to foster and enhance Australian research quality through the development of world-class scientific leaders.


Key activities and benefits:
* a network of new research laboratories in Australia. more...
* access to Europe's leading research institution. more...
* opportunities for Australia's best and brightest students. more...
* career acceleration for Australia's leading young scientists. more...

EMBL Australia is based at Monash University in Clayton, Victoria.

What's Happening?

8th May BioBreakfast - The Technological and Economic Opportunities of BioBanking in Australia

Tuesday 8th May, 7:15am - 9:00am
Cinema 1, Australian Centre for the Moving Image (ACMI), Federation Square, Melbourne

As the pharmaceutical industry and the wider research sector shifts rapidly towards personalised medicine and genomics combined with the increasing power of computational sciences, biobanking is clearly an emerging winner in terms of commercialisation opportunity and provision of quality research services for the future.

More news and events